Signaling pathways
-
BA4959 RuboxistaurinSummary: Ruboxistaurin (LY333531) is orally active. - BA4960 VTX-27Summary: VTX-27 is a selective inhibitor of protein kinase Cθ.
- BA4961 CC-90005Summary: CC-90005 is a potent, selective and orally active protein kinase C-theta inhibitor.
- BA4962 PKC-IN-1Summary: PKC-IN-1 is a reversible inhibitor.
- BA4963 PS432Summary: PS432 is an inhibitor.
- BA4964 ML192Summary: ML192 is a selective ligand antagonist.
-
BA4965 Z-Arg-SBzl acetateSummary: Substrate for bovine and human activated protein C. - BA4966 DL-erythro-DihydrosphingosineSummary: A potent and phospholipase A2 inhibitor.
- BA4967 DCPLA-MESummary: DCPLA-ME (DCPLAmethylester) is the methyl ester form of DCPLA.
- BA4969 MalantideSummary: Malantide is a synthetic dodecapeptide derived from a site that is phosphorylated on the beta subunit of phosphorylase kinase.